Derek D. Cyr

2.8k total citations
57 papers, 922 citations indexed

About

Derek D. Cyr is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Infectious Diseases. According to data from OpenAlex, Derek D. Cyr has authored 57 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 16 papers in Surgery and 6 papers in Infectious Diseases. Recurrent topics in Derek D. Cyr's work include Atrial Fibrillation Management and Outcomes (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Heart Failure Treatment and Management (10 papers). Derek D. Cyr is often cited by papers focused on Atrial Fibrillation Management and Outcomes (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Heart Failure Treatment and Management (10 papers). Derek D. Cyr collaborates with scholars based in United States, Canada and United Kingdom. Derek D. Cyr's co-authors include Keith A.A. Fox, Paul W. Armstrong, Matthew T. Roe, Harvey D. White, E. Magnus Ohman, Dorairaj Prabhakaran, Vance G. Fowler, Joseph E. Lucas, Joshua T. Thaden and Judith S. Hochman and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and European Heart Journal.

In The Last Decade

Derek D. Cyr

51 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derek D. Cyr United States 20 450 150 133 132 120 57 922
Inbar Raber United States 14 348 0.8× 127 0.8× 86 0.6× 52 0.4× 71 0.6× 26 692
Arunima Misra United States 16 499 1.1× 176 1.2× 192 1.4× 223 1.7× 23 0.2× 45 1.1k
Lei Hou China 17 207 0.5× 131 0.9× 105 0.8× 149 1.1× 23 0.2× 51 793
Adrija Hajra United States 17 318 0.7× 166 1.1× 98 0.7× 111 0.8× 40 0.3× 81 877
Nicola Potere Italy 17 278 0.6× 202 1.3× 151 1.1× 465 3.5× 55 0.5× 35 1.2k
Li-Jen Lin Taiwan 17 523 1.2× 246 1.6× 228 1.7× 153 1.2× 108 0.9× 38 1.1k
Jae Won Yang South Korea 16 120 0.3× 138 0.9× 138 1.0× 217 1.6× 21 0.2× 75 1.2k
Yuling Fu Canada 25 1.5k 3.3× 493 3.3× 99 0.7× 159 1.2× 74 0.6× 64 1.8k
Christian M. Jespersen Denmark 17 364 0.8× 190 1.3× 108 0.8× 184 1.4× 21 0.2× 46 832

Countries citing papers authored by Derek D. Cyr

Since Specialization
Citations

This map shows the geographic impact of Derek D. Cyr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek D. Cyr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek D. Cyr more than expected).

Fields of papers citing papers by Derek D. Cyr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek D. Cyr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek D. Cyr. The network helps show where Derek D. Cyr may publish in the future.

Co-authorship network of co-authors of Derek D. Cyr

This figure shows the co-authorship network connecting the top 25 collaborators of Derek D. Cyr. A scholar is included among the top collaborators of Derek D. Cyr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek D. Cyr. Derek D. Cyr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gunn, Alexander, Derek D. Cyr, Adrian F. Hernandez, et al.. (2025). Sacubitril/Valsartan Versus Valsartan Initiation in Patients Naïve to Renin–angiotensin System Inhibitors: Insights from PARAGLIDE-HF. European Journal of Heart Failure. 27(8). 1418–1425. 1 indexed citations
2.
Brown, David R., Derek D. Cyr, Lisa Wruck, et al.. (2025). COVID-19 prevention is shaped by polysocial risk: A cross-sectional study of vaccination and testing disparities in underserved populations. PLoS ONE. 20(7). e0328779–e0328779.
3.
Peters, Anthony E., Shuang Li, Derek D. Cyr, et al.. (2025). Influence of ejection fraction on outcomes with sacubitril/valsartan in patients with worsening heart failure with EF>40%: The PARAGLIDE-HF Trial. American Heart Journal. 289. 158–167.
4.
Harrington, Josephine, Anna Giczewska, Vishal N. Rao, et al.. (2025). Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index. JACC Heart Failure. 14(3). 102768–102768. 1 indexed citations
5.
Rambarat, Paula, Derek D. Cyr, Jonathan Ward, et al.. (2025). Effects of angiotensin-neprilysin inhibition in women vs men: Insights from PARAGLIDE-HF. American Heart Journal. 288. 41–51. 1 indexed citations
6.
Shoji, Satoshi, Derek D. Cyr, Adrian F. Hernandez, et al.. (2024). Win Ratio Analyses Using a Modified Hierarchical Composite Outcome: Insights From PARAGLIDE-HF. American Heart Journal. 280. 70–78. 1 indexed citations
7.
Fudim, Marat, Derek D. Cyr, Jonathan H. Ward, et al.. (2024). Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial. Journal of Cardiac Failure. 30(12). 1568–1577. 5 indexed citations
8.
Rao, Vishal N., Derek D. Cyr, Lisa Wruck, et al.. (2023). Electronic health record characterization and outcomes of heart failure with preserved ejection fraction. American Heart Journal. 263. 1–14. 1 indexed citations
9.
Barnett, Adam S., Derek D. Cyr, Shaun G. Goodman, et al.. (2018). Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF. International Journal of Cardiology. 257. 78–83. 13 indexed citations
10.
Yan, Andrew T., Matthew T. Roe, Megan L. Neely, et al.. (2018). Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes. Coronary Artery Disease. 29(6). 469–476. 4 indexed citations
11.
12.
Andell, Pontus, Stefan James, Christopher P. Cannon, et al.. (2015). TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN ANALYSIS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal of the American College of Cardiology. 65(10). A114–A114. 1 indexed citations
13.
Keenan, Melissa M., Beiyu Liu, Xiaohu Tang, et al.. (2015). ACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate. PLoS Genetics. 11(10). e1005599–e1005599. 40 indexed citations
14.
Durheim, Michael T., Derek D. Cyr, Renato D. Lópes, et al.. (2015). Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial. International Journal of Cardiology. 202. 589–594. 34 indexed citations
15.
16.
Cyr, Derek D., Yuliya Lokhnygina, Richard C. Becker, et al.. (2014). OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL. Journal of the American College of Cardiology. 63(12). A371–A371. 2 indexed citations
17.
Voora, Deepak, Derek D. Cyr, Joseph E. Lucas, et al.. (2013). Aspirin Exposure Reveals Novel Genes Associated With Platelet Function and Cardiovascular Events. Journal of the American College of Cardiology. 62(14). 1267–1276. 44 indexed citations
18.
Chan, Mark Y., Min Lin, Joseph Lucas, et al.. (2012). Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor. Thrombosis and Haemostasis. 108(12). 1180–1191. 34 indexed citations
19.
Cyr, Derek D., Joseph E. Lucas, J. Will Thompson, et al.. (2011). Characterization of Serum Proteins Associated with IL28B Genotype among Patients with Chronic Hepatitis C. PLoS ONE. 6(7). e21854–e21854. 22 indexed citations
20.
Bellet, Jane S., et al.. (2011). Clinical and dermoscopic features of 88 scalp naevi in 39 children. British Journal of Dermatology. 165(1). 137–143. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inbar Raber Breakdown of academic impact, for papers by Arunima Misra Breakdown of academic impact, for papers by Lei Hou Breakdown of academic impact, for papers by Adrija Hajra Breakdown of academic impact, for papers by Nicola Potere Breakdown of academic impact, for papers by Li-Jen Lin Breakdown of academic impact, for papers by Jae Won Yang Breakdown of academic impact, for papers by Yuling Fu Breakdown of academic impact, for papers by Christian M. Jespersen
Rankless by CCL
2026